154 related articles for article (PubMed ID: 1796714)
41. Mechanism of action of cis-dichlorodiammineplatinum(II).
Zwelling LA; Kohn KW
Cancer Treat Rep; 1979; 63(9-10):1439-44. PubMed ID: 387221
[TBL] [Abstract][Full Text] [Related]
42. DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity.
Zwelling LA; Anderson T; Kohn KW
Cancer Res; 1979 Feb; 39(2 Pt 1):365-9. PubMed ID: 570092
[TBL] [Abstract][Full Text] [Related]
43. Immunospecific protein of 34.5 kDa from DNA-protein cross-links induced by cis- and trans-diamminedichloroplatinum.
Woźniak K; Walter Z
Cell Biol Int; 2002; 26(6):495-503. PubMed ID: 12119176
[TBL] [Abstract][Full Text] [Related]
44. DNA-DNA interstrand cross-linking by cis-diamminedichloroplatinum(II): N7(dG)-to-N7(dG) cross-linking at 5'-d(GC) in synthetic oligonucleotides.
Huang H; Woo J; Alley SC; Hopkins PB
Bioorg Med Chem; 1995 Jun; 3(6):659-69. PubMed ID: 7582944
[TBL] [Abstract][Full Text] [Related]
45. Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.
Calsou P; Frit P; Salles B
Nucleic Acids Res; 1992 Dec; 20(23):6363-8. PubMed ID: 1475197
[TBL] [Abstract][Full Text] [Related]
46. DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues.
Brabec V; Leng M
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5345-9. PubMed ID: 8506383
[TBL] [Abstract][Full Text] [Related]
47. Cleavage by restriction enzymes of DNA modified with the antitumour drug cis-diamminedichloroplatinum(II).
Balcarová Z; Mrázek J; Kleinwächter V; Brabec V
Gen Physiol Biophys; 1992 Dec; 11(6):579-88. PubMed ID: 1338050
[TBL] [Abstract][Full Text] [Related]
48. Fragility of telomeres after bleomycin and cisplatin combined treatment measured in human leukocytes with the Comet-FISH technique.
Arutyunyan R; Rapp A; Greulich KO; Hovhannisyan G; Haroutiunian S; Gebhart E
Exp Oncol; 2005 Mar; 27(1):38-42. PubMed ID: 15812355
[TBL] [Abstract][Full Text] [Related]
49. Binding of the Escherichia coli UvrAB proteins to the DNA mono- and diadducts of cis-[N-2-amino-N-2-methylamino-2,2,1-bicycloheptane]dichloroplatinum(II ) and cisplatin. Analysis of the factors controlling recognition and proof of monoadduct-mediated UvrB-DNA cross-linking.
Lambert B; Jestin JL; Bréhin P; Oleykowski C; Yeung AT; Mailliet P; Prétot C; Le Pecq JB; Jacquemin-Sablon A; Chottard JC
J Biol Chem; 1995 Sep; 270(36):21251-7. PubMed ID: 7673159
[TBL] [Abstract][Full Text] [Related]
50. In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication.
Ciccarelli RB; Solomon MJ; Varshavsky A; Lippard SJ
Biochemistry; 1985 Dec; 24(26):7533-40. PubMed ID: 3004558
[TBL] [Abstract][Full Text] [Related]
51. Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum(II).
Zwelling LA; Kohn KW; Ross WE; Ewig RA; Anderson T
Cancer Res; 1978 Jun; 38(6):1762-8. PubMed ID: 565680
[TBL] [Abstract][Full Text] [Related]
52. cis-Diamminedichloroplatinum(II) (DDP)-induced crosslinking and crosslink removal in L1210 cells in vitro after theophylline co-treatment.
Ducore JM
Biochem Pharmacol; 1986 Feb; 35(4):607-11. PubMed ID: 3947390
[TBL] [Abstract][Full Text] [Related]
53. Solution structure of a cisplatin-induced DNA interstrand cross-link.
Huang H; Zhu L; Reid BR; Drobny GP; Hopkins PB
Science; 1995 Dec; 270(5243):1842-5. PubMed ID: 8525382
[TBL] [Abstract][Full Text] [Related]
54. Reaction of nucleic acids with cis-diamminedichloroplatinum(II): interstrand cross-links.
Rahmouni A; Leng M
Biochemistry; 1987 Nov; 26(23):7229-34. PubMed ID: 3427071
[TBL] [Abstract][Full Text] [Related]
55. DNA-protein cross-linking in L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
Olinski R; Briggs RC
Mol Biol Rep; 1991 May; 15(2):81-6. PubMed ID: 1749377
[TBL] [Abstract][Full Text] [Related]
56. Apoptosis induction and DNA interstrand cross-link formation by cytotoxic trans-[PtCl2(NH(CH3)2)(NHCH(CH3)2) : cross-linking between d(G) and complementary d(C) within oligonucleotide duplexes.
Montero EI; Pérez JM; Schwartz A; Fuertes MA; Malinge JM; Alonso C; Leng M; Navarro-Ranninger C
Chembiochem; 2002 Jan; 3(1):61-7. PubMed ID: 17590955
[TBL] [Abstract][Full Text] [Related]
57. DNA topology on an increase in positive writhing number of DNA: conformation changes in the time course of cis-diamminedichloroplatinum(II)-DNA adducts.
Kobayashi S; Nakamura Y; Maehara T; Hamashima H; Sasatsu M; Asano K; Ohishi Y; Tanaka A
Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1053-60. PubMed ID: 11558585
[TBL] [Abstract][Full Text] [Related]
58. Antibodies against cisplatin-modified DNA and cisplatin-modified (di)nucleotides.
Terheggen PM; Floot BG; Lempers EL; van Tellingen O; Begg AC; den Engelse L
Cancer Chemother Pharmacol; 1991; 28(3):185-91. PubMed ID: 1855275
[TBL] [Abstract][Full Text] [Related]
59. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
Fichtinger-Schepman AM; van der Veer JL; den Hartog JH; Lohman PH; Reedijk J
Biochemistry; 1985 Jan; 24(3):707-13. PubMed ID: 4039603
[TBL] [Abstract][Full Text] [Related]
60. Formation and stability of interstrand cross-links induced by cis- and trans-diamminedichloroplatinum (II) in the DNA of Saccharomyces cerevisiae strains differing in repair capacity.
Wilborn F; Brendel M
Curr Genet; 1989 Dec; 16(5-6):331-8. PubMed ID: 2692851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
